Blog - Rose Hill Life Sciences

Rose Hill Apothecary Executes First Major International Export Deal, Supplying Research-Grade Psilocybin to Brazil

Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025

Rose Hill Life Sciences Executes Exclusive License Agreement with Johns Hopkins University for Restoration of Motor Function Post-Neurological Injury Using Psychedelics

Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman as Strategic Advisor

Psilocybin Shows Promise in Treating OCD and Tourette’s Syndrome

A person sitting calmly, symbolizing the potential mental health benefits of psilocybin in promoting optimism and reducing depression.

Psilocybin Research Shows Promise in Boosting Optimism for Depression Treatment

An image of psilocybin mushrooms growing in nature.

Psilocybin Shows Promise in Treating Eating Disorders

Rose Hill Announces Addition of Two Senior Advisors to Advisory Team

Magic Mushrooms Beyond the Medical – Legalization and Decriminalization

The Outlook of the Psychedelic Industry